Bon Natural Life Limited (BON)
Automate Your Wheel Strategy on BON
With Tiblio's Option Bot, you can configure your own wheel strategy including BON - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BON
- Rev/Share 13.3881
- Book/Share 24.9012
- PB 0.0726
- Debt/Equity 0.1663
- CurrentRatio 2.4197
- ROIC 0.0185
- MktCap 3857427.0
- FreeCF/Share -1.0583
- PFCF -2.0465
- PE 8.0067
- Debt/Assets 0.1182
- DivYield 0
- ROE 0.0099
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
XI'AN, China, May 22, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales cooperation agreement with Shanghai Risesun International Trade Co., Ltd., a leading functional ingredient distributor in China.
Read More
BON Debuts Groundbreaking Broccoli-Derived Sleep Wellness Line, Reshaping the Sleep Health Market through Innovative Technology
Published: May 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
XI'AN, China, May 13, 2025 (GLOBE NEWSWIRE) -- BON Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the natural health and personal care sectors, today announced the groundbreaking launch of its sleep health product series. Developed using the proprietary “Glucoraphanin-Myrosinase” delivery system (patent-pending), the Company intends for this product to dramatically enhance the bio-activity (the extent to which something is absorbed and utilized by the body) of glucoraphanin, a vital bio-active compound in broccoli and will be launched under the Company's owned brand.
Read More
These Seven Tiny Stocks Are Eating Up 72% Of Nasdaq Volume Today. Here Is The Fine Print.
Published: April 29, 2025 by: Investors Business Daily
Sentiment: Neutral
Volume is running higher on the Nasdaq on Tuesday. But the action is dominated by these seven tiny stocks.
Read More
BON Announces Unlocking Broccoli's Nutritional Power: Advanced Delivery System for Glucoraphanin Activation
Published: April 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
XI'AN, China, April 08, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation addresses nutritional critical challenges through a patent-pending Glucoraphanin-Myrosinase co-delivery system that significantly enhances the bio-activity of glucoraph anin, a key bio-active compound in broccoli. Broccoli stands as a nutrient-rich super food containing glucoraphanin-the vegetable's key bio-active compound that could metabolically converted into sulforaphane within biological systems.
Read More
BON Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments
Published: April 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
XI'AN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced between October 2024 to January 2025, our company achieved groundbreaking progress in the bio-manufacturing technology of tea pigments, attaining an industrial-leading yields rate of 12-16% while maintaining purity levels surpassing 95%. Demonstrating significant biological properties including lipid-lowering, blood glucose reduction, antioxidant effects, and anti-peptic ulcers, tea pigments exhibit broad applicability across multiple health sectors.
Read More
BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
XI'AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term.
Read More
Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering
Published: March 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
XI'AN, China, March 17, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has priced a best efforts offering of units as described below for aggregate gross proceeds to the Company of $12 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering of ordinary units (or pre-funded units in lieu of such ordinary units) comprised of 8,333,332 shares of the Company's Class A ordinary shares (or pre-funded warrants in …
Read More
About Bon Natural Life Limited (BON)
- IPO Date 2021-06-24
- Website https://www.bnlus.com
- Industry Packaged Foods
- CEO Mr. Yongwei Hu
- Employees 97